A common mistake is underestimating the operational dependencies around EPCS. The article shows that success depends on legal, IT, pharmacy, medical staff, and administrative coordination, plus advance communication with retail pharmacies. Teams also underestimate how fragile adoption is when authentication, auditing, or approval steps are confusing, because users then fall back to paper workflows.
Why EPCS rollouts fail at the operational layer
EPCS usually fails less because the technology is unavailable and more because the rollout is treated as a software deployment instead of a cross-functional operating change. The real dependency chain includes controlled substances workflows, legal and compliance review, pharmacy operations, medical staff approval paths, and support from IT and administrators. If any of those steps are left ambiguous, users create workarounds instead of adopting the electronic process.
A second failure pattern is that the rollout is designed around the internal organisation and not the downstream pharmacy ecosystem. Prescribers may be ready before retail pharmacies, or pharmacy staff may not be prepared for the new verification flow, which turns a “live” launch into a partial deployment. That is why communication, testing, and cutover planning have to extend beyond the hospital’s own boundaries.
Authentication, auditability, and approval steps must feel unambiguous
The article’s deeper point is that adoption depends on whether the authentication and approval path is simple enough to use under time pressure. If clinicians cannot tell which step is required, who must approve, or what happens when an electronic step fails, the electronic path feels slower than paper. In practice, that is enough to push people back to legacy workflows even when the system is technically working.
Auditability also matters because EPCS is not just a convenience upgrade. It is part of a control environment where the organisation must be able to prove who initiated, authenticated, signed, and transmitted the prescription. If the workflow creates confusion around identity verification, signing, or exception handling, the control weakens precisely at the point where the organisation expects it to reduce risk.
That is why clear role design, clean approvals, and predictable fallback rules are as important as system uptime. EPCS adoption is fragile when users have to make judgment calls about whether a step was completed correctly, because ambiguity invites manual bypasses and inconsistent practice.
Getting the transition right means managing behaviour, not just software
Healthcare organisations often underestimate the behavioural change involved in moving prescribers away from paper and toward controlled electronic workflows. The system must fit real clinical tempo, especially in high-pressure settings where interruptions are common. If the process is too slow, too many prompts appear, or support staff cannot resolve issues quickly, users will ration their attention and keep paper as a backup habit.
Advance education, staged go-live support, and pharmacy-facing coordination reduce that risk because they turn EPCS into an operational routine rather than a special event. The strongest implementations treat the first weeks as a supervised change window, not a finished state. That allows teams to catch workflow friction, pharmacy mismatches, and approval bottlenecks before they harden into local workarounds.
Risk and Threat Considerations
EPCS introduces risk when organisations assume the control will be adopted simply because it is mandated. If authentication is confusing or approval paths are unreliable, users may fall back to paper, which creates inconsistency, weakens traceability, and can reintroduce process gaps the electronic workflow was meant to reduce.
Failure mechanism: Poorly coordinated rollout design, unclear authentication or audit steps, and weak downstream pharmacy readiness drive workarounds, delayed adoption, and parallel paper processing.
Impact: The organisation loses process consistency and visibility, and it may be left with a control that exists on paper but is not used reliably in practice.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5 and NIST CSF 2.0 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | IA-2 — Identification and Authentication (Organizational Users) | EPCS depends on reliable clinician authentication before prescribing controlled substances. |
| AU-2 — Event Logging | EPCS needs traceable signing and approval actions for auditability and accountability. | |
| AC-2 — Account Management | EPCS rollout depends on correct role assignment and access for clinicians and staff. | |
| Recommendation — Enforce strong user authentication for prescribers before electronic signing. Log each prescribing, approval, and transmission event with attributable identity data. Assign and review prescriber roles and access before enabling EPCS. | ||
| NIST CSF 2.0 | PR.AA-05 — Identity Management, Authentication and Access Control | The question turns on dependable authentication and access controls in the prescribing workflow. |
| GV.OC-01 — Organizational Context | EPCS rollout succeeds only when legal, clinical, pharmacy, and IT ownership is coordinated. | |
| Recommendation — Require consistent authentication and access control for controlled-substance workflows. Define cross-functional ownership for the EPCS operating model and rollout. | ||
Practitioner Guidance
What to prioritise: Treat EPCS as a workflow change programme first and a technical deployment second. The highest-value work is aligning pharmacy, clinical, legal, IT, and administrative owners on exactly how prescribing, approval, exception handling, and pharmacy transmission will work end to end.
What to verify: Before go-live, verify that clinicians can complete the full signing path without ambiguity, that retail pharmacies understand the new process, and that audit logs clearly reflect the identity and approval sequence the organisation expects. If any of those cannot be demonstrated in testing, the rollout is not ready.
Practitioner takeaway: The best EPCS rollouts minimise judgment at the point of care, because every unclear step increases the chance that users revert to paper or create local shortcuts.
